Logo image of SSKN

STRATA SKIN SCIENCES INC (SSKN) Stock Price, Quote, News and Overview

NASDAQ:SSKN - Nasdaq - US86272A3059 - Common Stock - Currency: USD

2.02  -0.04 (-1.7%)

After market: 2.02 0 (0%)

SSKN Quote, Performance and Key Statistics

STRATA SKIN SCIENCES INC

NASDAQ:SSKN (7/24/2025, 8:05:09 PM)

After market: 2.02 0 (0%)

2.02

-0.04 (-1.7%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.79
52 Week Low2.01
Market Cap8.42M
Shares4.17M
Float2.57M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12/amc
IPO10-28 2005-10-28


SSKN short term performance overview.The bars show the price performance of SSKN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

SSKN long term performance overview.The bars show the price performance of SSKN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SSKN is 2.02 USD. In the past month the price decreased by -12.17%. In the past year, price decreased by -39.52%.

STRATA SKIN SCIENCES INC / SSKN Daily stock chart

SSKN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.64 218.59B
ISRG INTUITIVE SURGICAL INC 60.7 175.13B
BSX BOSTON SCIENTIFIC CORP 37.53 157.13B
SYK STRYKER CORP 31.66 151.59B
MDT MEDTRONIC PLC 16.79 118.29B
BDX BECTON DICKINSON AND CO 13.03 52.63B
EW EDWARDS LIFESCIENCES CORP 29.49 44.46B
IDXX IDEXX LABORATORIES INC 48.24 44.23B
RMD RESMED INC 30.12 40.10B
GEHC GE HEALTHCARE TECHNOLOGY 16.69 35.15B
DXCM DEXCOM INC 52.57 34.01B
PHG KONINKLIJKE PHILIPS NVR- NY 15.95 24.88B

About SSKN

Company Profile

SSKN logo image STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Company Info

STRATA SKIN SCIENCES INC

5 Walnut Grove Dr Ste 140

Horsham PENNSYLVANIA 19044 US

CEO: Robert J. Moccia

Employees: 106

SSKN Company Website

SSKN Investor Relations

Phone: 12156193200

STRATA SKIN SCIENCES INC / SSKN FAQ

What is the stock price of STRATA SKIN SCIENCES INC today?

The current stock price of SSKN is 2.02 USD. The price decreased by -1.7% in the last trading session.


What is the ticker symbol for STRATA SKIN SCIENCES INC stock?

The exchange symbol of STRATA SKIN SCIENCES INC is SSKN and it is listed on the Nasdaq exchange.


On which exchange is SSKN stock listed?

SSKN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for STRATA SKIN SCIENCES INC stock?

8 analysts have analysed SSKN and the average price target is 9.18 USD. This implies a price increase of 354.46% is expected in the next year compared to the current price of 2.02. Check the STRATA SKIN SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is STRATA SKIN SCIENCES INC worth?

STRATA SKIN SCIENCES INC (SSKN) has a market capitalization of 8.42M USD. This makes SSKN a Nano Cap stock.


How many employees does STRATA SKIN SCIENCES INC have?

STRATA SKIN SCIENCES INC (SSKN) currently has 106 employees.


What are the support and resistance levels for STRATA SKIN SCIENCES INC (SSKN) stock?

STRATA SKIN SCIENCES INC (SSKN) has a resistance level at 2.35. Check the full technical report for a detailed analysis of SSKN support and resistance levels.


Is STRATA SKIN SCIENCES INC (SSKN) expected to grow?

The Revenue of STRATA SKIN SCIENCES INC (SSKN) is expected to grow by 3.13% in the next year. Check the estimates tab for more information on the SSKN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy STRATA SKIN SCIENCES INC (SSKN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does STRATA SKIN SCIENCES INC (SSKN) stock pay dividends?

SSKN does not pay a dividend.


When does STRATA SKIN SCIENCES INC (SSKN) report earnings?

STRATA SKIN SCIENCES INC (SSKN) will report earnings on 2025-08-12, after the market close.


What is the Price/Earnings (PE) ratio of STRATA SKIN SCIENCES INC (SSKN)?

STRATA SKIN SCIENCES INC (SSKN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.27).


What is the Short Interest ratio of STRATA SKIN SCIENCES INC (SSKN) stock?

The outstanding short interest for STRATA SKIN SCIENCES INC (SSKN) is 0.14% of its float. Check the ownership tab for more information on the SSKN short interest.


SSKN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SSKN Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SSKN. Both the profitability and financial health of SSKN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SSKN Financial Highlights

Over the last trailing twelve months SSKN reported a non-GAAP Earnings per Share(EPS) of -2.27. The EPS increased by 24.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.71%
ROE -342.83%
Debt/Equity 5.71
Chartmill High Growth Momentum
EPS Q2Q%42%
Sales Q2Q%0.86%
EPS 1Y (TTM)24.33%
Revenue 1Y (TTM)3.3%

SSKN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to SSKN. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 54.06% and a revenue growth 3.13% for SSKN


Ownership
Inst Owners29.52%
Ins Owners3.91%
Short Float %0.14%
Short Ratio0.23
Analysts
Analysts85
Price Target9.18 (354.46%)
EPS Next Y54.06%
Revenue Next Year3.13%